GAUSH MEDITECH (02407) expects revenue in the first half of the year to decrease by approximately 7.1% year-on-year to 10.7%.
Gaoshi Medical (02407) announced that it expects the group to achieve revenue of approximately RMB 583.2 million to 607 million for the six months ending June 30, 2026, compared to approximately RMB 653.1 million for the six months ending June 30, 2025, representing a decrease of about 7.1% to 10.7%.
GAUSH MEDITECH (02407) announced that it expects the group to achieve revenue of approximately RMB 583.2 million to 607 million for the six months ending June 30, 2026, compared to revenue of approximately RMB 653.1 million for the six months ending June 30, 2025, representing a decrease of about 7.1% to 10.7%.
Related Articles
KEEN OCEAN (08070) has issued a positive profit alert, expecting a mid-term net profit of approximately HKD 23 million, an increase of about 161.4% year-on-year.
CSPC PHARMA (01093): The Phase Ib/II clinical trial of SYS 6090 injection for the treatment of colorectal cancer has officially launched at the first research center in China.
WuXi AppTec (603259.SH) plans to launch an A-share employee stock ownership plan in 2026.
KEEN OCEAN (08070) has issued a positive profit alert, expecting a mid-term net profit of approximately HKD 23 million, an increase of about 161.4% year-on-year.
CSPC PHARMA (01093): The Phase Ib/II clinical trial of SYS 6090 injection for the treatment of colorectal cancer has officially launched at the first research center in China.
WuXi AppTec (603259.SH) plans to launch an A-share employee stock ownership plan in 2026.
RECOMMEND
